210 related articles for article (PubMed ID: 231610)
1. Cholinergic inhibition of catecholamine-stimulable cyclic AMP accumulation in murine atria.
Brown JH
J Cyclic Nucleotide Res; 1979 Dec; 5(6):423-33. PubMed ID: 231610
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
3. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
Barovsky K; Pedone C; Brooker G
Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic regulation of phosphatidylinositol turnover and cyclic nucleotide metabolism in the heart.
Brown JH; Masters SB
Fed Proc; 1984 Aug; 43(11):2613-7. PubMed ID: 6086410
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
Ray A; MacLeod KM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
[TBL] [Abstract][Full Text] [Related]
7. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
Barovsky K; Brooker G
Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
[TBL] [Abstract][Full Text] [Related]
8. Activation of muscarinic cholinergic receptors in mouse neuroblastoma x rat glioma hybrid cells: rapid induction of enhanced capacity of prostaglandin E1 receptors to stimulate cyclic AMP accumulation.
Thomas JM; Hoffman BB
J Pharmacol Exp Ther; 1990 Feb; 252(2):616-22. PubMed ID: 2156056
[TBL] [Abstract][Full Text] [Related]
9. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
Pasquali D; Rani CS; Deery WJ
Mol Pharmacol; 1992 Jan; 41(1):163-7. PubMed ID: 1310140
[TBL] [Abstract][Full Text] [Related]
10. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
11. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
Evans T; Martin MW; Hughes AR; Harden TK
Mol Pharmacol; 1985 Jan; 27(1):32-7. PubMed ID: 2981400
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
Griffin MT; Ehlert FJ
J Pharmacol Exp Ther; 1992 Oct; 263(1):221-5. PubMed ID: 1328607
[TBL] [Abstract][Full Text] [Related]
14. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
15. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
Weber HW; Chung FZ; Day K; Appleman MM
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
17. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
Tanner LI; Harden TK; Wells JN; Martin MW
Mol Pharmacol; 1986 May; 29(5):455-60. PubMed ID: 2422535
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of pertussis toxin on adenosine and muscarinic inhibition of cyclic AMP accumulation in canine ventricular myocytes.
Kubalak SW; Newman WH; Webb JG
J Mol Cell Cardiol; 1991 Feb; 23(2):199-205. PubMed ID: 1648626
[TBL] [Abstract][Full Text] [Related]
19. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.
Challiss RA; Adams D; Mistry R; Nicholson CD
Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342
[TBL] [Abstract][Full Text] [Related]
20. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
Brown JH; Goldstein D
Mol Pharmacol; 1986 Dec; 30(6):566-70. PubMed ID: 3023810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
